Research on the mechanism of compound mylabris capsules regulating ferroptosis in lung adenocarcinoma based on bioinformatics and experimental validation
CMC exerts antitumor effects in LUAD by regulating ferroptosis-related targets such as CA9, EZH2, NQO1, and TERT. This study reported for the first time that CMC alleviated LUAD by regulating ferroptosis.
Authors
- Huihua Shen
- Yuan Yuan (ORCID: https://orcid.org/0000-0002-2880-1577)
- Cancan Wang (ORCID: https://orcid.org/0000-0002-5647-8412)
- Rui Wang (ORCID: https://orcid.org/0000-0003-4917-4573)
- Yawei Xu (ORCID: https://orcid.org/0000-0002-5129-186X)
- Dong Cao (ORCID: https://orcid.org/0000-0002-6849-4719)
- Jiangtao Wang (ORCID: https://orcid.org/0000-0001-7323-4690)
- Jian Q. Yu (ORCID: https://orcid.org/0000-0002-4538-1666)
- Li Wu (ORCID: https://orcid.org/0009-0009-7680-616X)
- Juan Liu (ORCID: https://orcid.org/0000-0002-4440-9065)
Institutions
- Xinjiang Medical University (CN)
- Tumor Hospital of Xinjiang Medical University (CN)
- Fuling Center Hospital of Chongqing (CN)
- Urumqi General Hospital of PLA (CN)
- Sixth Affiliated Hospital of Xinjiang Medical University (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1097/js9.0000000000003735
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00